These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Combined nitoman-pimozide treatment of Huntington's chorea and other hyperkinetic syndromes. Fog R; Pakkenberg H Acta Neurol Scand; 1970; 46(2):249-51. PubMed ID: 4246984 [No Abstract] [Full Text] [Related]
14. Lithium therapy in Huntington's chorea and tardive dyskinesia. Dalén P Lancet; 1973 Jan; 1(7794):107-8. PubMed ID: 4118636 [No Abstract] [Full Text] [Related]
15. Pharmacologic approaches to the treatment of Huntington's disease. Venuto CS; McGarry A; Ma Q; Kieburtz K Mov Disord; 2012 Jan; 27(1):31-41. PubMed ID: 21997232 [TBL] [Abstract][Full Text] [Related]
16. Dopaminergic manipulations and its effects on neurogenesis and motor function in a transgenic mouse model of Huntington's disease. Choi ML; Begeti F; Oh JH; Lee SY; O'Keeffe GC; Clelland CD; Tyers P; Cho ZH; Kim YB; Barker RA Neurobiol Dis; 2014 Jun; 66():19-27. PubMed ID: 24561069 [TBL] [Abstract][Full Text] [Related]
17. Tetrabenazine in the treatment of hyperkinetic movement disorders. Kenney C; Jankovic J Expert Rev Neurother; 2006 Jan; 6(1):7-17. PubMed ID: 16466307 [TBL] [Abstract][Full Text] [Related]
18. Pathophysiology and therapeutic strategies in Huntington's chorea. Waddington JL; Cross AJ Lancet; 1980 Jul; 2(8187):206-7. PubMed ID: 6105376 [No Abstract] [Full Text] [Related]
19. Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders. Guay DR Am J Geriatr Pharmacother; 2010 Aug; 8(4):331-73. PubMed ID: 20869622 [TBL] [Abstract][Full Text] [Related]